WBH Advisory’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,513
| Closed | -$213K | – | 299 |
|
|
2022
Q2 | $213K | Hold |
3,513
| – | – | 0.03% | 290 |
|
|
2022
Q1 | $203K | Hold |
3,513
| – | – | 0.02% | 307 |
|
|
2021
Q4 | $250K | Hold |
3,513
| – | – | 0.03% | 289 |
|
|
2021
Q3 | $263K | Hold |
3,513
| – | – | 0.04% | 257 |
|
|
2021
Q2 | $260K | Hold |
3,513
| – | – | 0.04% | 241 |
|
|
2021
Q1 | $259K | Hold |
3,513
| – | – | 0.04% | 239 |
|
|
2020
Q4 | $271K | Sell |
3,513
-100
| -3% | -$7.71K | 0.05% | 227 |
|
|
2020
Q3 | $205K | Hold |
3,613
| – | – | 0.04% | 239 |
|
|
2020
Q2 | $210K | Buy |
+3,613
| New | +$210K | 0.05% | 226 |
|
|
2020
Q1 | – | Sell |
-3,762
| Closed | -$210K | – | 235 |
|
|
2019
Q4 | $210K | Buy |
+3,762
| New | +$210K | 0.04% | 231 |
|
|
2019
Q3 | – | Sell |
-3,762
| Closed | -$201K | – | 239 |
|
|
2019
Q2 | $201K | Hold |
3,762
| – | – | 0.05% | 227 |
|
|
2019
Q1 | $207K | Buy |
+3,762
| New | +$207K | 0.05% | 225 |
|
|
2018
Q4 | – | Sell |
-3,963
| Closed | -$235K | – | 237 |
|
|
2018
Q3 | $235K | Buy |
3,963
+1
| +0% | +$59 | 0.06% | 228 |
|
|
2018
Q2 | $216K | Buy |
+3,962
| New | +$216K | 0.06% | 222 |
|
|
2016
Q1 | – | Sell |
-4,958
| Closed | -$250 | – | 203 |
|
|
2015
Q4 | $250 | Buy |
4,958
+2
| +0% | – | 0.09% | 166 |
|
|
2015
Q3 | $226K | Buy |
4,956
+1
| +0% | +$46 | 0.09% | 174 |
|
|
2015
Q2 | $289K | Buy |
4,955
+1
| +0% | +$58 | 0.11% | 160 |
|
|
2015
Q1 | $273 | Sell |
4,954
-100
| -2% | -$6 | 0.08% | 171 |
|
|
2014
Q4 | $253K | Buy |
+5,054
| New | +$253K | 0.1% | 174 |
|
|
2014
Q3 | – | Sell |
-5,154
| Closed | -$225K | – | 215 |
|
|
2014
Q2 | $225K | Buy |
5,154
+3
| +0.1% | +$131 | 0.09% | 195 |
|
|
2014
Q1 | $214K | Buy |
+5,151
| New | +$214K | 0.09% | 198 |
|